Results 91 to 100 of about 506,611 (220)

The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development

, 2020
The UK introduced a pneumococcal conjugate vaccine (PCV) that covered seven serotypes (PCV-7) for routine infant immunisation in 2006 which was replaced with a 13 valent PCV (PCV-13) in 2010 [1].
Slack, M, Czudek, C, Ellsbury, G, Vyse, A, Campling, J, James Campling, Carole Czudek, Mary Slack, Gillian Ellsbury, Andrew Vyse   +9 more
core   +1 more source

Approaches to vaccination of adults against pneumococcal disease in different countries of the world

Журнал инфектологии
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination  against  pneumococcal infection is recommended
A. S. Korovkin, Yu. I. Obukhov, E. N. Syatchikhina   +2 more
doaj   +1 more source

Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia : Extent of coverage by pneumococcal vaccines

Annals of Saudi Medicine, 2005
BACKGROUND : Serogroup distribution of sterile site pneumococcal isolates varies between developing and developed countries as well as between different geographical regions.
Al-Mazrou Abdulrahman, Twum-Danso Kingsley, Al Zamil Fahad, Kambal Abdelmageed   +3 more
doaj  

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

Risk Management and Healthcare Policy, 2018
Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT, Yousif LIE, Spoorenberg SMC, van Overveld FJ   +3 more
doaj  

Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia

Nature Communications
Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction on pneumococcal carriage. Here we assess the impact of 13-valent pneumococcal conjugate vaccine (PCV13) introduction on nasopharyngeal pneumococcal ...
Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar, Paige Skoko, Laura Boelsen, Cattram Nguyen, Purevsuren Batsaikhan, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, Bilegtsaikhan Tsolmon, Sodbayar Demberelsuren, Belinda D. Ortika, Casey L. Pell, Ashleigh Wee-Hee, Monica L. Nation, Jason Hinds, Eileen M. Dunne, E. Kim Mulholland, Catherine Satzke   +19 more
doaj   +1 more source

The New Era of Pneumococcal Vaccination in Adults: What Is Next?

Vaccines
Streptococcus pneumoniae remains the leading cause of community-acquired pneumonia in adults and bacterial meningitis in children worldwide. In addition to pneumonia, invasive pneumococcal diseases (IPDs), such as bacteremia and meningitis, pose a ...
Lale Ozisik
doaj   +1 more source

Vaccine [PDF]

We applied the indirect cohort method to estimate effectiveness of 10-valent pneumococcal conjugate vaccine (PCV10) among young children in Brazil. Cases of invasive pneumococcal disease (IPD), i.e., Streptococcus pneumoniae, detected in normally sterile

core  

Pneumococcal conjugate vaccines—a European perspective

International Journal of Medical Microbiology, 2004
Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and acute otitis media in children and adults worldwide. In the age group of < 2 years the incidence of invasive pneumococcal disease ranges from approximately 14 cases per 100,000 in Germany and the Netherlands and more than 90 per 100,000 children in Spain.
openaire   +2 more sources

Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

, 2009
Pneumococcal conjugate vaccine (PCV7), Herd immunity, Pneumococcal disease, Germany,
Reinert, Ralf René, Christa Claes, Johann-Matthias Schulenburg, Claes, Christa, Ralf Reinert, von der Schulenburg, Johann-Matthias Graf   +5 more
core   +1 more source

Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine

Journal of Pediatric Infection, 2011
Streptococcus pneumoniae (pneumococcus) is an important cause of serious infectious diseases, leading to death among children all over the world. The 7-valent pneumococcal conjugate vaccine (PCV7), which was introduced in 2000 to prevent pneumococcal infections, was included in the Childhood National Immunization Program of Turkey in November 2008 and ...
openaire   +2 more sources